Natalie I. Mazur

Utrecht, UT, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

Worldwide Impact of ACIP's 2025 Overhaul.

Worldwide Impact of ACIP's 2025 Overhaul.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: December 14, 2025

Pre-assembly of biomolecular condensate seeds drives RSV replication.

Pre-assembly of biomolecular condensate seeds drives RSV replication.

Journal: Nature

Published: January 24, 2025

Intranasal monoclonal antibodies do not prevent respiratory infection in a randomized, controlled experimental infection trial.

Intranasal monoclonal antibodies do not prevent respiratory infection in a randomized, controlled experimental infection trial.

Journal: npj drug discovery

Published: January 17, 2025

Understanding the interaction of upper respiratory tract infection with respiratory syncytial virus and Streptococcus pneumoniae using a human challenge model: a multicenter, randomized controlled study protocol.

Understanding the interaction of upper respiratory tract infection with respiratory syncytial virus and Streptococcus pneumoniae using a human challenge model: a multicenter, randomized controlled study protocol.

Journal: PloS one

Published: October 17, 2024

Regulatory workshop on standardisation of clinical procedures, endpoints and data robustness of human challenge studies - A stakeholder meeting report.

Regulatory workshop on standardisation of clinical procedures, endpoints and data robustness of human challenge studies - A stakeholder meeting report.

Journal: Biologicals : journal of the International Association of Biological Standardization

Published: September 25, 2024

Proof-of-principle of a technology transfer of a dried blood virus neutralisation assay to a Gavi-eligible country.

Proof-of-principle of a technology transfer of a dried blood virus neutralisation assay to a Gavi-eligible country.

Journal: BMJ global health

Published: July 25, 2024

Risk analysis for outpatient experimental infection as a pathway for affordable RSV vaccine development.

Risk analysis for outpatient experimental infection as a pathway for affordable RSV vaccine development.

Journal: NPJ vaccines

Published: July 17, 2024

From setbacks to success: lessons from the journey of RSV vaccine development.

From setbacks to success: lessons from the journey of RSV vaccine development.

Journal: Therapeutic advances in vaccines and immunotherapy

Published: July 12, 2024

Access to highly effective long-acting RSV-monoclonal antibodies for children in LMICs-reducing global inequity.

Access to highly effective long-acting RSV-monoclonal antibodies for children in LMICs-reducing global inequity.

Journal: The Lancet. Global health

Published: June 02, 2024

The respiratory syncytial virus vaccine and monoclonal antibody landscape: the road to global access.

The respiratory syncytial virus vaccine and monoclonal antibody landscape: the road to global access.

Journal: The Lancet. Infectious diseases

Published: May 17, 2024

Severe respiratory syncytial virus infection in children: burden, management, and emerging therapies.

Severe respiratory syncytial virus infection in children: burden, management, and emerging therapies.

Journal: Lancet (London, England)

Published: May 16, 2024

Daily intranasal palivizumab to prevent respiratory syncytial virus infection in healthy preterm infants: a phase 1/2b randomized placebo-controlled trial.

Daily intranasal palivizumab to prevent respiratory syncytial virus infection in healthy preterm infants: a phase 1/2b randomized placebo-controlled trial.

Journal: EClinicalMedicine

Published: September 01, 2023

Showing 1-12 of 30

Last Updated: 09/26/2026